Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • First-in-human phase 1/2a study of the novel nonfucosylated anti-CTLA-4 monoclonal antibody BMS-986218 +/- nivolumab in advanced solid tumors: Initial phase 1 results
    Meeting Abstract

    Friedman, C.; Ascierto, P.; Davar, D.; O'Hara, M.; Shapira-Frommer, R.; Dallos, M.; Khemka, V.; James, L.; Fischer, B.; Demes, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies
    Meeting Abstract

    Lin, C. C.; Garralda, E.; Schoffski, P.; Hong, D.; Siu, L.; Martin, M.; Maur, M.; Hui, R.; Soo, R.; Chiu, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Technical considerations for normalizing digital spatial profiling data with multiple within-patient samples
    Meeting Abstract

    Hether, T.; Howes, T.; Spencer, C.; Hollman, T.; Reeves, J.; Wells, D.; Friedman, C.; LaVallee, T.; Wolchok, J.; Warren, S.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Cytokine and immune subset signatures in patients with various solid and hematological malignancies treated with oncolytic vaccinia virus delivered by autologous stromal vascular fraction cells
    Meeting Abstract

    Draganov, D.; Santidrian, A.; Minev, I.; Nguyen, D.; Zamarin, D.; Marincola, F.; Minev, B.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Distinct immune signatures predicting clinical response to PD-1 blockade therapy in gynecological cancers revealed by high-dimensional immune profiling
    Meeting Abstract

    Muroyama, Y.; Muroyama, Y.; Manne, S.; Huang, A.; Mathew, D.; Chilukuri, L.; Greenplate, A.; Ohtani, T.; Zamarin, D.; Friedman, C.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19
    Meeting Abstract

    Smith, M.; Lara, O.; O'Cearbhaill, R.; Sutter, M.; Knisely, A.; McEachron, J.; Gabor, L.; Carr, C.; Blank, S.; Prasad-Hayes, M.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • ENGOT-en9/LEAP-001: A phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer
    Meeting Abstract

    Randall, L.; Marth, C.; Vulsteke, C.; Jesús Rubio, M.; Makker, V.; Braicu, I.; McNeish, I.; Madry, R.; Ayhan, A.; Hasegawa, K.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save